NCT05325814 is a clinical trial in Postoperative Patients, sponsored by Rigshospitalet, Denmark.

Who is sponsoring NCT05325814?

NCT05325814 is sponsored by Rigshospitalet, Denmark.

What condition does NCT05325814 study?

NCT05325814 studies Postoperative Patients.

Is NCT05325814 still recruiting?

NCT05325814 is currently completed. Last updated 19 April 2022.

Last reviewed 2022-04-19 · How we verify

NCT05325814

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Agreement Between Standard and Continuous Wireless Vital Sign Measurements

Completed Last updated 19 April 2022

What this trial tests

trial in Postoperative Patients in 20 participants. Completed in 22 July 2020.

Timeline

18 December 2019

Primary endpoint
22 July 2020

22 July 2020

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Status	Completed
Study type	OBSERVATIONAL
Enrollment	20
Start date	18 December 2019
Primary completion	22 July 2020
Estimated completion	22 July 2020
Sites	1 location across Denmark

Conditions studied

Postoperative Patients — all drugs for Postoperative Patients →

Sponsor

Rigshospitalet, Denmark

Who can join

Adults 60 to 110, any sex, with Postoperative Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients undergoing major surgery are at risk of postoperative complications. Continuous wireless monitoring outside the post-anesthesia or intensive care units may enable early detection of patient deterioration, but good accuracy of measurements is required. This validation study, which is part of the WARD-SX project, aimed to assess the agreement between vital signs recorded by standard and novel wireless devices

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05325814 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 19 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05325814.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing